Encompass Health (NYSE:EHC) Treasurer Edmund Fay Sells 11,937 Shares

Encompass Health Corporation (NYSE:EHC) Treasurer Edmund Fay sold 11,937 shares of the company’s stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $107.00, for a total transaction of $1,277,259.00. Following the sale, the treasurer owned 89,325 shares in the company, valued at $9,557,775. This represents a 11.79% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Encompass Health Trading Down 1.7%

NYSE:EHC traded down $1.87 during mid-day trading on Tuesday, hitting $106.75. 1,196,337 shares of the stock traded hands, compared to its average volume of 1,292,626. Encompass Health Corporation has a 52 week low of $92.53 and a 52 week high of $127.99. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.76. The stock has a market capitalization of $10.61 billion, a price-to-earnings ratio of 19.27, a PEG ratio of 2.05 and a beta of 0.70. The firm’s 50 day moving average is $103.94 and its two-hundred day moving average is $113.48.

Encompass Health (NYSE:EHC) last issued its earnings results on Thursday, February 5th. The company reported $1.46 earnings per share for the quarter, beating analysts’ consensus estimates of $1.29 by $0.17. The business had revenue of $3.09 billion during the quarter, compared to analyst estimates of $1.54 billion. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.Encompass Health’s revenue was up 9.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.17 EPS. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. On average, equities research analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be paid a dividend of $0.19 per share. The ex-dividend date is Wednesday, April 1st. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. Encompass Health’s dividend payout ratio is presently 13.72%.

Institutional Investors Weigh In On Encompass Health

Several large investors have recently bought and sold shares of EHC. Hsbc Holdings PLC lifted its position in shares of Encompass Health by 412.7% during the 4th quarter. Hsbc Holdings PLC now owns 276,194 shares of the company’s stock worth $29,606,000 after purchasing an additional 222,327 shares during the last quarter. Caitong International Asset Management Co. Ltd grew its holdings in shares of Encompass Health by 109.6% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 761 shares of the company’s stock worth $81,000 after buying an additional 398 shares during the last quarter. MidFirst Bank acquired a new stake in shares of Encompass Health during the fourth quarter worth $202,000. Virtu Financial LLC purchased a new stake in shares of Encompass Health in the fourth quarter valued at about $371,000. Finally, Dean Capital Management boosted its holdings in Encompass Health by 3.2% in the 4th quarter. Dean Capital Management now owns 19,763 shares of the company’s stock valued at $2,098,000 after purchasing an additional 611 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently issued reports on EHC. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, January 18th. Zacks Research downgraded shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Finally, Barclays raised their price objective on Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a report on Friday, February 6th. Two investment analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $143.29.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.